We concluded that high levels of serum uric acid (SUA) were associated with poor coronary collateral circulation (CCC) in patients with stable coronary artery disease (CAD). 1 We thank Koza et al for their comments on our manuscript. 2 It is still unclear as to whether SUA is an independent predictor of CAD. The utility of SUA as a cardiovascular risk factor has not been approved in meta-analyses. 3, 4 In contrast, there are several recent studies that supported the association between SUA and cardiovascular diseases (CVDs). [5] [6] [7] [8] [9] [10] [11] [12] [13] Kivity et al suggested that the association of SUA levels with CVD supported exploration of SUA as a risk marker of CVD in healthy populations. 9 Bickel et al showed a 5-fold increase in mortality in patients with uric acid >7.1 mg/dL versus those with SUA <5.1 mg/dL over a 2.2-year follow-up in patients with angiographically proven CAD. 10 In another study, SUA predicted an increased risk of cardiac and all-cause mortality independent of traditional cardiovascular risk factors, left ventricular function, C-reactive protein, and renal function across all subgroups of patients with CAD. 11 Furthermore, Lin et al found that high SUA levels were predictive of cardiac and all-cause mortality among patients with obstructive CAD defined by angiography in 1054 patients in a median followup of 3.1 years. 12 Additionally, Kaya et al found that high SUA levels on admission were independently associated with inhospital and long-term adverse outcomes in patients with STsegment elevation myocardial infarction who undergo primary percutaneous coronary intervention. 13 Several mechanisms that explain the relationship between SUA and CCC have been mentioned in our manuscript.
Further prospective clinical studies are needed to determine the causal association and its exact physiopathologic process and whether lowering SUA can provide survival benefit in patients at risk of CAD or in patients with established CAD.
